600873 梅花生物
2024/09 - 九个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额4,085,7125,228,9375,654,9543,734,3321,661,133
投资活动产生之现金流量净额(3,730,011)(1,509,146)(1,738,222)(386,834)(712,930)
筹资活动产生之现金流量净额(1,842,609)(3,108,097)(3,093,970)(1,570,882)(1,517,087)
汇率变动对现金及现金等价物的影响71,03540,12151,055(16,287)(38,270)
现金及现金等价物净增加/(减少)(1,415,873)651,815873,8171,760,328(607,154)
期初现金及现金等价物余额4,780,6144,128,8003,254,9831,494,6542,101,808
期末现金及现金等价物余额3,364,7424,780,6144,128,8003,254,9831,494,654